Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

Women using hair relaxers with alopecia had lower zinc levels, suggesting zinc deficiency might contribute to hair loss.

More severe hair loss is linked to more sexual dysfunction in both men and women.

Women with mixed alopecia experience more depression, anxiety, and stress than those with metabolic alopecia.

Diffuse unpatterned alopecia can affect donor areas, but treatment with finasteride and minoxidil can improve hair density.

Iron supplements combined with Quilib lotion effectively treat hair loss in people with iron deficiency anemia.

PRP treatment improves hair density and diameter in women with androgenetic alopecia.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

AGA causes permanent hair loss; minoxidil helps men, finasteride helps men, minoxidil somewhat helps women, estrogens/antiandrogens lack evidence for women.

Hair loss affects women's mental health more than men's, causing anxiety, low self-esteem, and social insecurity.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

The document concludes that proper diagnosis and a combination of medical, hair-care, and surgical treatments are important for managing alopecia in black women.

Alopecia significantly lowers women's quality of life, with psychological and social challenges, highlighting the importance of early treatment and support.

No link found between new male baldness genes and female hair loss.

Women with greater androgen sensitivity respond better to finasteride for hair loss.

Hair loss in women linked to higher sexual dysfunction risk.

AGA causes permanent hair loss; women use 2% minoxidil, men use 1 mg finasteride daily.

Androgens significantly affect female hair loss, and hormonal treatments may help.

High aldosterone and free testosterone levels link to female hair loss; testing aldosterone may predict hypertension risk.

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

The conclusion is that treatments like finasteride and minoxidil can prevent baldness progression and improve hair density, but more research is needed on other therapies.

Proper nutrition is crucial for healthy hair growth.

Dermoscopy shows that diffuse alopecia areata progresses through specific hair growth stages.

Diffuse alopecia is caused by various factors and can be managed with different treatments.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

2% topical minoxidil effectively treats female hair loss with minimal side effects.

Minoxidil 2% effectively treats female hair loss, promoting growth and density.

PRP injections increase hair density and diameter in female androgenetic alopecia patients.

A drug called cimetidine can help treat hair loss in women by blocking androgen receptors. However, it's not the first choice and needs more research.

CTE and FPHL are different hair loss types with unique causes.